 "Sequoia invests Rs 100 cr in La Renon Healthcare")
Ahmedabad-based La Renon Healthcare, a pharmaceutical research, marketing and manufacturing company, has raised Rs. 100 crore in first institutional funding (Series A) from Sequoia Capital.
The company will use the investment to strengthen its R&D capabilities and to expand into new categories within the chronic diseases management space, it said in a press statement.
Founded by Pankaj Singh, La Renon provides pharmaceutical products and services for various critical illnesses and diseases.
“Chronic diseases are fast becoming a major health risk for a majority of Indians, largely due to factors relating to the changing modern lifestyle. At La Renon, it is our aim to develop and market new and innovative solutions to address these chronic health issues," said Pankaj Singh, Founder, Chairman and CEO of La Reno.
The company will use the investment to strengthen its R&D capabilities and to expand into new categories within the chronic diseases management space, it said in a press statement.
Founded by Pankaj Singh, La Renon provides pharmaceutical products and services for various critical illnesses and diseases.
“Chronic diseases are fast becoming a major health risk for a majority of Indians, largely due to factors relating to the changing modern lifestyle. At La Renon, it is our aim to develop and market new and innovative solutions to address these chronic health issues," said Pankaj Singh, Founder, Chairman and CEO of La Reno.
You’ve reached your limit of {{free_limit}} free articles this month.
Subscribe now for unlimited access.
Already subscribed? Log in
Subscribe to read the full story →*Subscribe to Business Standard digital and get complimentary access to The New York Times
Smart Quarterly
₹900
3 Months
₹300/Month
SAVE 25%
Smart Essential
₹2,700
1 Year
₹225/Month
SAVE 46%
*Complimentary New York Times access for the 2nd year will be given after 12 months
Super Saver
₹3,900
2 Years
₹162/Month
Subscribe
Renews automatically, cancel anytime
Here’s what’s included in our digital subscription plans
Exclusive premium stories online
Over 30 premium stories daily, handpicked by our editors
Complimentary Access to The New York Times
News, Games, Cooking, Audio, Wirecutter & The Athletic
Business Standard Epaper
Digital replica of our daily newspaper — with options to read, save, and share
Curated Newsletters
Insights on markets, finance, politics, tech, and more delivered to your inbox
Market Analysis & Investment Insights
In-depth market analysis & insights with access to The Smart Investor
Archives
Repository of articles and publications dating back to 1997
Ad-free Reading
Uninterrupted reading experience with no advertisements
Seamless Access Across All Devices
Access Business Standard across devices — mobile, tablet, or PC, via web or app
SAVE 25%